FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

373739008: Topical neomycin (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2009. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1199039013 Topical neomycin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1212194011 Topical neomycin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1199039013 Topical neomycin (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1199039013 Topical neomycin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1212194011 Topical neomycin en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1212194011 Topical neomycin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Topical neomycin Is a Framycetin false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Neomycin sulfate ophthalmic agent Is a False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate otic solution Is a False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Framycetin sulfate [systemic] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Framycetin sulfate [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate 5 mg/mL eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate 0.5% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate 5 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Framycetin sulfate [ear] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin+hydrocortisone 0.5%/1.5% ear drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release solution for ear or eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin ear drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin ear ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin 0.5% ear drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Framycetin sulfate [skin] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin 0.5% cream BPC The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely framycetin sulfate 5 milligram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Framycetin sulfate 5 mg/g eye ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Topical neomycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely neomycin 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate+neomycin sulfate 1.5%/0.5% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/3.5gm/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Bacitracin zinc + polymyxin b sulphate 500unt/10000unt ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone + neomycin sulphate 1mg/3.5mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Dexamethasone sodium phospha + neomycin sulphate 0ns/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing framycetin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Topical neomycin Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    POSSIBLY EQUIVALENT TO association reference set

    Back to Start